Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC
Clinical trial NCT03093428 · COMPLETED
Trial details
- NCT number
- NCT03093428
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-09
- Primary completion
- 2020-04-09
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.